Cyfuse Biomedical K.K. (TYO:4892)

Cyfuse Biomedical K.K. Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3,726	3,052	3,873	4,437	2,413
Cash & Short-Term Investments	3,726	3,052	3,873	4,437	2,413
Cash Growth	22.08%	-21.20%	-12.71%	83.88%	16.46%
Accounts Receivable	5	20	17	13	57
Other Receivables	40	43	32	56	-
Receivables	45	63	49	69	57
Inventory	88	55	46	40	61
Prepaid Expenses	72	51	16	17	5
Other Current Assets	3	19	3	2	22
Total Current Assets	3,934	3,240	3,987	4,565	2,558
Property, Plant & Equipment	155	141	169	189	27
Long-Term Investments	173	131	53	55	55
Other Intangible Assets	3	4	4	5	4
Other Long-Term Assets	1	2	1	1	2
Total Assets	4,266	3,518	4,214	4,815	2,646
Accounts Payable	69	15	2	4	8
Accrued Expenses	12	16	19	25	6
Short-Term Debt	485	507	550	467	128
Current Portion of Long-Term Debt	184	18	18	77	72
Current Portion of Leases	-	-	-	-	8
Current Income Taxes Payable	63	59	47	74	74
Current Unearned Revenue	-	20	19	22	19
Other Current Liabilities	53	13	11	13	71
Total Current Liabilities	866	648	666	682	386
Long-Term Debt	642	327	345	363	359
Other Long-Term Liabilities	2	1	1	1	1
Total Liabilities	1,510	976	1,012	1,046	746
Common Stock	1,828	1,364	1,283	1,272	100
Additional Paid-In Capital	4,450	3,986	3,905	3,893	2,721
Retained Earnings	-3,622	-2,858	-1,986	-1,396	-922
Comprehensive Income & Other	100	50	-	-	1
Shareholders' Equity	2,756	2,542	3,202	3,769	1,900
Total Liabilities & Equity	4,266	3,518	4,214	4,815	2,646
Total Debt	1,311	852	913	907	567
Net Cash (Debt)	2,415	2,200	2,960	3,530	1,846
Net Cash Growth	9.77%	-25.68%	-16.15%	91.22%	19.48%
Net Cash Per Share	274.37	273.27	378.89	1323.28	3688.31
Filing Date Shares Outstanding	9.62	8.14	7.83	6.44	0.5
Total Common Shares Outstanding	9.62	8.14	7.83	6.44	0.5
Working Capital	3,068	2,592	3,321	3,883	2,172
Book Value Per Share	286.63	312.31	409.12	585.09	3796.20
Tangible Book Value	2,753	2,538	3,198	3,764	1,896
Tangible Book Value Per Share	286.31	311.82	408.60	584.31	3788.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.